Gerald B. Pier - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Microbiology Biology

289 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Taus NS, Cywes-Bentley C, Johnson WC, Pier GB, Fry LM, Mousel MR, Ueti MW. Immunization against a Conserved Surface Polysaccharide Stimulates Bovine Antibodies with Opsonic Killing Activity but Does Not Protect against Challenge. Pathogens (Basel, Switzerland). 10. PMID 34959553 DOI: 10.3390/pathogens10121598  0.321
2021 Pandey JP, Namboodiri AM, Nietert PJ, Knowles MR, Pace RG, Pier GB. Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 34246573 DOI: 10.1016/j.jcf.2021.06.011  0.371
2020 Cohen ND, Cywes-Bentley C, Kahn SM, Bordin AI, Bray JM, Wehmeyer SG, Pier GB. Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi. Plos One. 15: e0240479. PMID 33057397 DOI: 10.1371/journal.pone.0240479  0.301
2020 Flannery A, Le Berre M, Pier GB, O'Gara JP, Kilcoyne M. Glycomics Microarrays Reveal Differential In Situ Presentation of the Biofilm Polysaccharide Poly--acetylglucosamine on and Cell Surfaces. International Journal of Molecular Sciences. 21. PMID 32252300 DOI: 10.3390/Ijms21072465  0.366
2019 Soliman C, Pier GB, Ramsland PA. Antibody recognition of bacterial surfaces and extracellular polysaccharides. Current Opinion in Structural Biology. 62: 48-55. PMID 31874385 DOI: 10.1016/J.Sbi.2019.12.001  0.443
2019 D'Gama JD, Ma Z, Zhang H, Liu X, Fan H, Morris ERA, Cohen ND, Cywes-Bentley C, Pier GB, Waldor MK. A Conserved Streptococcal Virulence Regulator Controls the Expression of a Distinct Class of M-Like Proteins. Mbio. 10. PMID 31641092 DOI: 10.1128/Mbio.02500-19  0.379
2019 Hülsdünker J, Thomas OS, Haring E, Unger S, Gonzalo Núñez N, Tugues S, Gao Z, Duquesne S, Cywes-Bentley C, Oyardi O, Kirschnek S, Schmitt-Graeff A, Pabst O, Koenecke C, Duyster J, ... ... Pier GB, et al. Immunization against poly--acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity. Proceedings of the National Academy of Sciences of the United States of America. PMID 31527267 DOI: 10.1073/Pnas.1908549116  0.415
2019 Ramos Y, Rocha J, Hael AL, van Gestel J, Vlamakis H, Cywes-Bentley C, Cubillos-Ruiz JR, Pier GB, Gilmore MS, Kolter R, Morales DK. PolyGlcNAc-containing exopolymers enable surface penetration by non-motile Enterococcus faecalis. Plos Pathogens. 15: e1007571. PMID 30742693 DOI: 10.1371/Journal.Ppat.1007571  0.373
2019 Rocha JN, Dangott LJ, Mwangi W, Alaniz RC, Bordin AI, Cywes-Bentley C, Lawhon SD, Pillai SD, Bray JM, Pier GB, Cohen ND. PNAG-specific equine IgG mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG. Vaccine. PMID 30691984 DOI: 10.1016/J.Vaccine.2019.01.028  0.421
2018 Cristina L, McPartland L, Tran NQ, Meehan BM, Zhang Y, Tanweer Z, Wakabayashi S, Rock J, Kim T, Balasubramanian D, Audette R, Toosky M, Pinkham J, Rubin EJ, Lory S, ... Pier G, et al. Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymes. Molecular Microbiology. PMID 30556355 DOI: 10.1111/Mmi.14185  0.333
2018 Liang X, Gupta K, Quintero JR, Cernadas M, Kobzik L, Christou H, Pier GB, Owen CA, Çataltepe S. Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802002R. PMID 30462529 DOI: 10.1096/Fj.201802002R  0.396
2018 Cywes-Bentley C, Rocha JN, Bordin AI, Vinacur M, Rehman S, Zaidi TS, Meyer M, Anthony S, Lambert M, Vlock DR, Giguère S, Cohen ND, Pier GB. Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi. Plos Pathogens. 14: e1007160. PMID 30024986 DOI: 10.1371/Journal.Ppat.1007160  0.473
2018 Zaidi TS, Zaidi T, Pier GB. Antibodies to Conserved Surface Polysaccharides Protect Mice Against Bacterial Conjunctivitis. Investigative Ophthalmology & Visual Science. 59: 2512-2519. PMID 29847658 DOI: 10.1167/Iovs.18-23795  0.474
2018 Little DJ, Pfoh R, Le Mauff F, Bamford NC, Notte C, Baker P, Guragain M, Robinson H, Pier GB, Nitz M, Deora R, Sheppard DC, Howell PL. PgaB orthologues contain a glycoside hydrolase domain that cleaves deacetylated poly-β(1,6)-N-acetylglucosamine and can disrupt bacterial biofilms. Plos Pathogens. 14: e1006998. PMID 29684093 DOI: 10.1371/Journal.Ppat.1006998  0.321
2018 Stevenson TC, Cywes-Bentley C, Moeller TD, Weyant KB, Putnam D, Chang YF, Jones BD, Pier GB, DeLisa MP. Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies. Proceedings of the National Academy of Sciences of the United States of America. PMID 29555731 DOI: 10.1073/Pnas.1718341115  0.459
2018 Soliman C, Walduck AK, Yuriev E, Richards JS, Cywes-Bentley C, Pier GB, Ramsland PA. Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly--acetyl glucosamine. The Journal of Biological Chemistry. PMID 29449370 DOI: 10.1074/Jbc.Ra117.001170  0.363
2018 Rehman S, Ali NM, Pier GB, Liaqat I, Mazhar B. In vitro Susceptibility of Pseudomonas aeruginosa Isolated from Acute and Chronic Pulmonary Infection to Antibiotics, Lactobacillus Competition and Metal Nanoparticles Pakistan Journal of Zoology. 50. DOI: 10.17582/Journal.Pjz/2018.50.6.2165.2171  0.321
2017 Sanchez-Larrayoz AF, Elhosseiny NM, Chevrette MG, Fu Y, Giunta P, Spallanzani RG, Ravi K, Pier GB, Lory S, Maira-Litrán T. Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum. Journal of Immunology (Baltimore, Md. : 1950). PMID 28855313 DOI: 10.4049/Jimmunol.1700877  0.352
2017 Shanmugam M, Oyeniyi AO, Parthiban C, Gujjarlapudi SK, Pier GB, Ramasubbu N. Role of de-N-acetylase PgaB from Aggregatibacter actinomycetemcomitans in exopolysaccharide export in biofilm mode of growth. Molecular Oral Microbiology. PMID 28548373 DOI: 10.1111/Omi.12188  0.335
2017 Roux D, Weatherholt M, Clark B, Gadjeva M, Renaud D, Scott D, Skurnik D, Priebe GP, Pier G, Gerard C, Yoder-Himes DR. HOST IMMUNE RECOGNITION OF THE EPIDEMIC CYSTIC FIBROSIS PATHOGEN BURKHOLDERIA DOLOSA. Infection and Immunity. PMID 28348057 DOI: 10.1128/Iai.00765-16  0.404
2017 Yu L, Hisatsune J, Hayashi I, Tatsukawa N, Sato'o Y, Mizumachi E, Kato F, Hirakawa H, Pier GB, Sugai M. A Novel Repressor of the ica Locus Discovered in Clinically Isolated Super-Biofilm-Elaborating Staphylococcus aureus. Mbio. 8. PMID 28143981 DOI: 10.1128/Mbio.02282-16  0.341
2017 Søe NH, Jensen NV, Jensen AL, Koch J, Poulsen SS, Pier GB, Johansen HK. Active and Passive Immunization Against Staphylococcus aureus Periprosthetic Osteomyelitis in Rats. In Vivo (Athens, Greece). 31: 45-50. PMID 28064219 DOI: 10.21873/Invivo.11023  0.32
2016 Zhao G, Zaidi TS, Bozkurt-Guzel C, Zaidi TH, Lederer JA, Priebe GP, Pier GB. Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens. Investigative Ophthalmology & Visual Science. 57: 6797-6804. PMID 28002842 DOI: 10.1167/Iovs.16-20358  0.437
2016 França A, Pérez-Cabezas B, Correia A, Pier GB, Cerca N, Vilanova M. Staphylococcus epidermidis Biofilm-Released Cells Induce a Prompt and More Marked In vivo Inflammatory-Type Response than Planktonic or Biofilm Cells. Frontiers in Microbiology. 7: 1530. PMID 27729907 DOI: 10.3389/Fmicb.2016.01530  0.392
2016 Ferreirinha P, Pérez-Cabezas B, Correia A, Miyazawa B, França A, Carvalhais V, Faustino A, Cordeiro-da-Silva A, Teixeira L, Pier GB, Cerca N, Vilanova M. Poly-N-acetyl glucosamine production by Staphylococcus epidermidis cells increases their in vivo pro-inflammatory effect. Infection and Immunity. PMID 27481237 DOI: 10.1128/Iai.00290-16  0.409
2016 Guillard T, Pons S, Roux D, Pier GB, Skurnik D. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. PMID 27248008 DOI: 10.1002/Bies.201500180  0.348
2016 Kar S, Arjunaraja S, Akkoyunlu M, Pier GB, Snapper CM. Distinct Mechanisms Underlie Boosted Polysaccharide-Specific IgG Responses Following Secondary Challenge with Intact Gram-Negative versus Gram-Positive Extracellular Bacteria. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183619 DOI: 10.4049/Jimmunol.1600082  0.383
2016 França A, Carvalhais V, Vilanova M, Pier GB, Cerca N. Characterization of an in vitro fed-batch model to obtain cells released from S. epidermidis biofilms. Amb Express. 6: 23. PMID 27001438 DOI: 10.1186/S13568-016-0197-9  0.361
2016 Song J, Wilhelm CL, Wangdi T, Maira-Litran T, Lee SJ, Raetz M, Sturge CR, Mirpuri J, Pei J, Grishin NV, McSorley SJ, Gewirtz AT, Bäumler AJ, Pier GB, Galán JE, et al. Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella Typhi. Cell. 164: 827-828. PMID 26919416 DOI: 10.1016/J.Cell.2016.02.015  0.334
2016 Skurnik D, Cywes-Bentley C, Pier GB. The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG. Expert Review of Vaccines. 1-13. PMID 26918288 DOI: 10.1586/14760584.2016.1159135  0.378
2016 Skurnik D, Roux D, Pons S, Guillard T, Lu X, Cywes-Bentley C, Pier GB. Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae. The Journal of Antimicrobial Chemotherapy. PMID 26747103 DOI: 10.1093/Jac/Dkv448  0.47
2016 Mellata M, Mitchell NM, Schödel F, Curtiss R, Pier GB. Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis. Vaccine. 34: 656-62. PMID 26707217 DOI: 10.1016/J.Vaccine.2015.12.014  0.473
2015 Korneev KV, Arbatsky NP, Molinaro A, Palmigiano A, Shaikhutdinova RZ, Shneider MM, Pier GB, Kondakova AN, Sviriaeva EN, Sturiale L, Garozzo D, Kruglov AA, Nedospasov SA, Drutskaya MS, Knirel YA, et al. Structural Relationship of the Lipid A Acyl Groups to Activation of Murine Toll-Like Receptor 4 by Lipopolysaccharides from Pathogenic Strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa. Frontiers in Immunology. 6: 595. PMID 26635809 DOI: 10.3389/Fimmu.2015.00595  0.347
2015 Gauguet S, D'Ortona S, Ahnger-Pier K, Duan B, Surana NK, Lu R, Cywes-Bentley C, Gadjeva M, Shan Q, Priebe GP, Pier GB. Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. Infection and Immunity. 83: 4003-14. PMID 26216419 DOI: 10.1128/Iai.00037-15  0.411
2015 Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant F, Messika J, Ricard JD, Mekalanos JJ, Lory S, Pier GB, Skurnik D. Fitness cost of antibiotic susceptibility during bacterial infection. Science Translational Medicine. 7: 297ra114. PMID 26203082 DOI: 10.1126/Scitranslmed.Aab1621  0.382
2015 Roux D, Cywes-Bentley C, Zhang YF, Pons S, Konkol M, Kearns D, Little DJ, Howell PL, Skurnik D, Pier GB. Identification of Poly-N-acetyl Glucosamine as a Major Polysaccharide Component of the Bacillus Subtilis Biofilm Matrix. The Journal of Biological Chemistry. PMID 26078454 DOI: 10.1074/Jbc.M115.648709  0.342
2014 Cerca F, França A, Pérez-Cabezas B, Carvalhais V, Ribeiro A, Azeredo J, Pier G, Cerca N, Vilanova M. Dormant bacteria within Staphylococcus epidermidis biofilms have low inflammatory properties and maintain tolerance to vancomycin and penicillin after entering planktonic growth. Journal of Medical Microbiology. 63: 1274-83. PMID 25053799 DOI: 10.1099/Jmm.0.073163-0  0.377
2014 Zaidi T, Zaidi T, Cywes-Bentley C, Lu R, Priebe GP, Pier GB. Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye. Infection and Immunity. 82: 3483-91. PMID 24914214 DOI: 10.1128/Iai.01951-14  0.446
2014 Lu X, Skurnik D, Pozzi C, Roux D, Cywes-Bentley C, Ritchie JM, Munera D, Gening ML, Tsvetkov YE, Nifantiev NE, Waldor MK, Pier GB. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli. Mbio. 5: e00974-14. PMID 24667709 DOI: 10.1128/Mbio.00974-14  0.456
2014 Carvalhais V, França A, Cerca F, Vitorino R, Pier GB, Vilanova M, Cerca N. Dormancy within Staphylococcus epidermidis biofilms: a transcriptomic analysis by RNA-seq. Applied Microbiology and Biotechnology. 98: 2585-96. PMID 24504458 DOI: 10.1007/S00253-014-5548-3  0.325
2014 França A, Carvalhais V, Maira-Litrán T, Vilanova M, Cerca N, Pier G. Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood. Pathogens and Disease. 70: 444-8. PMID 24391077 DOI: 10.1111/2049-632X.12130  0.317
2014 Döring G, Bragonzi A, Paroni M, Aktürk FF, Cigana C, Schmidt A, Gilpin D, Heyder S, Born T, Smaczny C, Kohlhäufl M, Wagner TO, Loebinger MR, Bilton D, Tunney MM, ... ... Pier GB, et al. BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 156-63. PMID 24183915 DOI: 10.1016/J.Jcf.2013.10.007  0.353
2013 Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, ... Pier GB, et al. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proceedings of the National Academy of Sciences of the United States of America. 110: 20747-52. PMID 24248354 DOI: 10.1073/Pnas.1221552110  0.37
2013 Skurnik D, Roux D, Aschard H, Cattoir V, Yoder-Himes D, Lory S, Pier GB. A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries. Plos Pathogens. 9: e1003582. PMID 24039572 DOI: 10.1371/Journal.Ppat.1003582  0.323
2013 Pier GB. Will there ever be a universal Staphylococcus aureus vaccine? Human Vaccines & Immunotherapeutics. 9: 1865-76. PMID 23793522 DOI: 10.4161/Hv.25182  0.414
2013 França A, Vilanova M, Cerca N, Pier GB. Monoclonal antibody raised against PNAG has variable effects on static S. epidermidis biofilm accumulation in vitro. International Journal of Biological Sciences. 9: 518-20. PMID 23781145 DOI: 10.7150/Ijbs.6102  0.454
2013 Zaidi T, Zaidi T, Yoong P, Pier GB. Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. Investigative Ophthalmology & Visual Science. 54: 4430-8. PMID 23737477 DOI: 10.1167/Iovs.13-11701  0.433
2013 Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litràn T, ... ... Pier GB, et al. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proceedings of the National Academy of Sciences of the United States of America. 110: E2209-18. PMID 23716675 DOI: 10.1073/Pnas.1303573110  0.504
2013 Py BF, Gonzalez SF, Long K, Kim MS, Kim YA, Zhu H, Yao J, Degauque N, Villet R, Ymele-Leki P, Gadjeva M, Pier GB, Carroll MC, Yuan J. Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity. Immunity. 38: 1063-72. PMID 23684986 DOI: 10.1016/J.Immuni.2013.01.015  0.402
2013 Babra C, Tiwari JG, Pier G, Thein TH, Sunagar R, Sundareshan S, Isloor S, Hegde NR, de Wet S, Deighton M, Gibson J, Costantino P, Wetherall J, Mukkur T. The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia. Folia Microbiologica. 58: 469-74. PMID 23446489 DOI: 10.1007/S12223-013-0232-Z  0.362
2013 Søe NH, Jensen NV, Nürnberg BM, Jensen AL, Koch J, Poulsen SS, Pier G, Johansen HK. A novel knee prosthesis model of implant-related osteomyelitis in rats. Acta Orthopaedica. 84: 92-7. PMID 23409845 DOI: 10.3109/17453674.2013.773121  0.323
2013 Reidy T, Rittenberg A, Dwyer M, D'Ortona S, Pier G, Gadjeva M. Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection. The Journal of Biological Chemistry. 288: 8269-78. PMID 23372160 DOI: 10.1074/Jbc.M112.351064  0.404
2013 Kamei A, Wu W, Traficante DC, Koh AY, Van Rooijen N, Pier GB, Priebe GP. Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia. The Journal of Infectious Diseases. 207: 39-49. PMID 23100569 DOI: 10.1093/Infdis/Jis657  0.363
2013 Gening ML, Tsvetkov YE, Titov DV, Gerbst AG, Yudina ON, Grachev AA, Shashkov AS, Vidal S, Imberty A, Saha T, Kand D, Talukdar P, Pier GB, Nifantiev NE. Linear and cyclic oligo-β-(1 → 6)-D-glucosamines: Synthesis, conformations, and applications for design of a vaccine and oligodentate glycoconjugates Pure and Applied Chemistry. 85: 1879-1891. DOI: 10.1351/Pac-Con-12-09-06  0.378
2012 Pozzi C, Wilk K, Lee JC, Gening M, Nifantiev N, Pier GB. Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens. Plos One. 7: e46648. PMID 23077517 DOI: 10.1371/Journal.Pone.0046648  0.458
2012 Tamang DL, Pirzai W, Priebe GP, Traficante DC, Pier GB, Falck JR, Morisseau C, Hammock BD, McCormick BA, Gronert K, Hurley BP. Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. Journal of Immunology (Baltimore, Md. : 1950). 189: 4960-9. PMID 23045615 DOI: 10.4049/Jimmunol.1201922  0.417
2012 Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. Plos One. 7: e43813. PMID 22970144 DOI: 10.1371/Journal.Pone.0043813  0.478
2012 Komarova BS, Tsvetkov YE, Pier GB, Nifantiev NE. Synthesis of pentasaccharides corresponding to the glycoform II of the outer core region of the Pseudomonas aeruginosa lipopolysaccharide. Carbohydrate Research. 360: 56-68. PMID 22940177 DOI: 10.1016/J.Carres.2012.07.019  0.391
2012 Roux D, Pier GB, Skurnik D. Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes. The Journal of Antimicrobial Chemotherapy. 67: 2785-7. PMID 22899807 DOI: 10.1093/Jac/Dks335  0.448
2012 Yoong P, Cywes-Bentley C, Pier GB. Poly-N-acetylglucosamine expression by wild-type Yersinia pestis is maximal at mammalian, not flea, temperatures. Mbio. 3: e00217-12. PMID 22893384 DOI: 10.1128/Mbio.00217-12  0.368
2012 Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infection and Immunity. 80: 3381-8. PMID 22825448 DOI: 10.1128/Iai.06096-11  0.518
2012 Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 1188-97. PMID 22806596 DOI: 10.1093/Cid/Cis624  0.461
2012 Zaidi TS, Zaidi T, Pier GB, Priebe GP. Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology. Infection and Immunity. 80: 3706-12. PMID 22802348 DOI: 10.1128/Iai.00249-12  0.389
2012 Pier GB. The challenges and promises of new therapies for cystic fibrosis. The Journal of Experimental Medicine. 209: 1235-9. PMID 22753926 DOI: 10.1084/Jem.20121248  0.365
2012 Yoong P, Pier GB. Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infection and Immunity. 80: 2894-904. PMID 22665379 DOI: 10.1128/Iai.06360-11  0.446
2012 Bentancor LV, Camacho-Peiro A, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. Journal of Bacteriology. 194: 3950-60. PMID 22609912 DOI: 10.1128/Jb.06769-11  0.398
2012 Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, Loftus BJ, Pier GB, Fey PD, Massey RC, O'Gara JP. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. Plos Pathogens. 8: e1002626. PMID 22496652 DOI: 10.1371/Journal.Ppat.1002626  0.415
2012 Skurnik D, Davis MR, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, ... ... Pier GB, et al. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. The Journal of Infectious Diseases. 205: 1709-18. PMID 22448004 DOI: 10.1093/Infdis/Jis254  0.456
2012 Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infection and Immunity. 80: 651-6. PMID 22104104 DOI: 10.1128/Iai.05653-11  0.498
2012 Pier GB. Refers to: J.-P. Rasigade, N. Sicot, F. Laurent, G. Lina, F. Vandenesch, J. Etienne, A history of Panton-Valentine leukocidin (PVL)-associated infection protects against death in PVL-associated pneumonia, Vaccine 29 (25) (2011) 4185-4186. Vaccine. 30: 2045-6. PMID 21821077 DOI: 10.1016/J.Vaccine.2011.07.120  0.315
2011 Zaidi T, Reidy T, D'Ortona S, Fichorova R, Pier G, Gadjeva M. CD74 deficiency ameliorates Pseudomonas aeruginosa-induced ocular infection. Scientific Reports. 1: 58. PMID 22355577 DOI: 10.1038/Srep00058  0.387
2011 Lopez-Medina E, Neubauer MM, Pier GB, Koh AY. RNA isolation of Pseudomonas aeruginosa colonizing the murine gastrointestinal tract. Journal of Visualized Experiments : Jove. PMID 21989513 DOI: 10.3791/3293  0.362
2011 Cerca F, Andrade F, França Â, Andrade EB, Ribeiro A, Almeida AA, Cerca N, Pier G, Azeredo J, Vilanova M. Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. Journal of Medical Microbiology. 60: 1717-1724. PMID 21799197 DOI: 10.1099/Jmm.0.031922-0  0.384
2011 Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infection and Immunity. 79: 3455-64. PMID 21628521 DOI: 10.1128/Iai.00157-11  0.468
2011 Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection. Infection and Immunity. 79: 1289-99. PMID 21149583 DOI: 10.1128/Iai.01139-10  0.432
2010 Koh AY, Mikkelsen PJ, Smith RS, Coggshall KT, Kamei A, Givskov M, Lory S, Pier GB. Utility of in vivo transcription profiling for identifying Pseudomonas aeruginosa genes needed for gastrointestinal colonization and dissemination. Plos One. 5: e15131. PMID 21170272 DOI: 10.1371/Journal.Pone.0015131  0.41
2010 Hermos CR, Yoong P, Pier GB. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 1138-46. PMID 20946065 DOI: 10.1086/656742  0.416
2010 Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, Goldmann DA, Huang SS, Datta R, Lee JC, Pier GB. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. The Journal of Clinical Investigation. 120: 3220-33. PMID 20739753 DOI: 10.1172/Jci42748  0.503
2010 Gadjeva M, Nagashima J, Zaidi T, Mitchell RA, Pier GB. Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. Plos Pathogens. 6: e1000826. PMID 20361053 DOI: 10.1371/Journal.Ppat.1000826  0.432
2010 Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, et al. Alveolar inflammation in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 9: 217-27. PMID 20347403 DOI: 10.1016/J.Jcf.2010.03.001  0.353
2010 Yoong P, Pier GB. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proceedings of the National Academy of Sciences of the United States of America. 107: 2241-6. PMID 20133867 DOI: 10.1073/Pnas.0910344107  0.502
2010 Campodónico VL, Llosa NJ, Grout M, Döring G, Maira-Litrán T, Pier GB. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infection and Immunity. 78: 746-55. PMID 19995892 DOI: 10.1128/Iai.00806-09  0.495
2010 Gadjeva M, Paradis-Bleau C, Priebe GP, Fichorova R, Pier GB. Caveolin-1 modifies the immunity to Pseudomonas aeruginosa. Journal of Immunology (Baltimore, Md. : 1950). 184: 296-302. PMID 19949109 DOI: 10.4049/Jimmunol.0900604  0.457
2010 Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infection and Immunity. 78: 764-72. PMID 19948836 DOI: 10.1128/Iai.01093-09  0.47
2010 Kamei A, Koh AY, Gadjeva M, Priebe GP, Lory S, Pier GB. Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model. The Journal of Infectious Diseases. 201: 71-80. PMID 19938976 DOI: 10.1086/648616  0.355
2010 Zaidi TS, Zaidi T, Pier GB. Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis. Investigative Ophthalmology & Visual Science. 51: 2085-93. PMID 19892865 DOI: 10.1167/Iovs.09-4139  0.425
2009 Koh AY, Priebe GP, Ray C, Van Rooijen N, Pier GB. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infection and Immunity. 77: 5300-10. PMID 19805527 DOI: 10.1128/Iai.00501-09  0.437
2009 Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. Journal of Bacteriology. 191: 5953-63. PMID 19633088 DOI: 10.1128/Jb.00647-09  0.371
2009 Van Gennip M, Christensen LD, Alhede M, Phipps R, Jensen PØ, Christophersen L, Pamp SJ, Moser C, Mikkelsen PJ, Koh AY, Tolker-Nielsen T, Pier GB, Høiby N, Givskov M, Bjarnsholt T. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 117: 537-46. PMID 19594494 DOI: 10.1111/J.1600-0463.2009.02466.X  0.419
2009 Levy H, Murphy A, Zou F, Gerard C, Klanderman B, Schuemann B, Lazarus R, García KC, Celedón JC, Drumm M, Dahmer M, Quasney M, Schneck K, Reske M, Knowles MR, ... Pier GB, et al. IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatric Pulmonology. 44: 580-93. PMID 19431193 DOI: 10.1002/Ppul.21026  0.345
2009 Pérez MM, Prenafeta A, Valle J, Penadés J, Rota C, Solano C, Marco J, Grilló MJ, Lasa I, Irache JM, Maira-Litran T, Jiménez-Barbero J, Costa L, Pier GB, de Andrés D, et al. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl β-1,6 glucosamine specific antibody production using biofilm-embedded bacteria Vaccine. 27: 2379-2386. PMID 19428854 DOI: 10.1016/J.Vaccine.2009.02.005  0.468
2009 Feodorova VA, Pan'kina LN, Savostina EP, Kuznetsov OS, Konnov NP, Sayapina LV, Dentovskaya SV, Shaikhutdinova RZ, Ageev SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, ... Pier GB, et al. Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens. Vaccine. 27: 2240-2250. PMID 19428838 DOI: 10.1016/J.Vaccine.2009.02.020  0.413
2009 Bajmoczi M, Gadjeva M, Alper SL, Pier GB, Golan DE. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. American Journal of Physiology. Cell Physiology. 297: C263-77. PMID 19386787 DOI: 10.1152/Ajpcell.00527.2008  0.433
2009 Feodorova VA, Pan'kina LN, Savostina EP, Kuznetsov OS, Konnov NP, Sayapina LV, Dentovskaya SV, Shaikhutdinova RZ, Ageev SA, Lindner B, Kondakova AN, Kocharova NA, Senchenkova SN, Holst O, Pier GB, et al. Yersinia pestis Live Vaccine with Improved Characteristics Procedia in Vaccinology. 1: 97-100. DOI: 10.1016/J.Provac.2009.07.017  0.44
2008 Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. Journal of Immunology (Baltimore, Md. : 1950). 181: 4965-75. PMID 18802100 DOI: 10.4049/Jimmunol.181.7.4965  0.465
2008 Zaidi T, Pier GB. Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection. Infection and Immunity. 76: 4720-5. PMID 18644881 DOI: 10.1128/Iai.00496-08  0.462
2008 Qiu D, Eisinger VM, Head NE, Pier GB, Yu HD. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology (Reading, England). 154: 2119-30. PMID 18599839 DOI: 10.1099/Mic.0.2008/017368-0  0.374
2008 Levy H, Kalish LA, Cannon CL, García KC, Gerard C, Goldmann D, Pier GB, Weiss ST, Colin AA. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatric Pulmonology. 43: 463-71. PMID 18361452 DOI: 10.1002/Ppul.20794  0.334
2008 Zaidi T, Bajmoczi M, Zaidi T, Golan DE, Pier GB. Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. Investigative Ophthalmology & Visual Science. 49: 1000-9. PMID 18326723 DOI: 10.1167/Iovs.07-0993  0.407
2008 Vergara-Irigaray M, Maira-Litrán T, Merino N, Pier GB, Penadés JR, Lasa I. Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface. Microbiology (Reading, England). 154: 865-77. PMID 18310032 DOI: 10.1099/Mic.0.2007/013292-0  0.384
2008 Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. Plos Pathogens. 4: e35. PMID 18282097 DOI: 10.1371/Journal.Ppat.0040035  0.332
2008 Campodónico VL, Gadjeva M, Paradis-Bleau C, Uluer A, Pier GB. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends in Molecular Medicine. 14: 120-33. PMID 18262467 DOI: 10.1016/J.Molmed.2008.01.002  0.431
2008 Döring G, Pier GB. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine. 26: 1011-24. PMID 18242792 DOI: 10.1016/J.Vaccine.2007.12.007  0.39
2007 Knirel YA, Dentovskaya SV, Bystrova OV, Kocharova NA, Senchenkova SN, Shaikhutdinova RZ, Titareva GM, Bakhteeva IV, Lindner B, Pier GB, Anisimov AP. Relationship of the lipopolysaccharide structure of Yersinia pestis to resistance to antimicrobial factors. Advances in Experimental Medicine and Biology. 603: 88-96. PMID 17966406 DOI: 10.1007/978-0-387-72124-8_7  0.312
2007 Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, et al. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine. 25: 7620-8. PMID 17913308 DOI: 10.1016/J.Vaccine.2007.08.055  0.347
2007 Kowalski MP, Dubouix-Bourandy A, Bajmoczi M, Golan DE, Zaidi T, Coutinho-Sledge YS, Gygi MP, Gygi SP, Wiemer EA, Pier GB. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science (New York, N.Y.). 317: 130-2. PMID 17615361 DOI: 10.1126/Science.1142311  0.693
2007 Cerca N, Jefferson KK, Maira-Litrán T, Pier DB, Kelly-Quintos C, Goldmann DA, Azeredo J, Pier GB. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infection and Immunity. 75: 3406-13. PMID 17470540 DOI: 10.1128/Iai.00078-07  0.785
2007 Pier GB. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. International Journal of Medical Microbiology : Ijmm. 297: 277-95. PMID 17466590 DOI: 10.1016/J.Ijmm.2007.03.012  0.438
2007 Cerca N, Maira-Litrán T, Jefferson KK, Grout M, Goldmann DA, Pier GB. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proceedings of the National Academy of Sciences of the United States of America. 104: 7528-33. PMID 17446272 DOI: 10.1073/Pnas.0700630104  0.485
2007 Anisimov AP, Shaikhutdinova RZ, Pan'kina LN, Feodorova VA, Savostina EP, Bystrova OV, Lindner B, Mokrievich AN, Bakhteeva IV, Titareva GM, Dentovskaya SV, Kocharova NA, Senchenkova SN, Holst O, Devdariani ZL, ... ... Pier GB, et al. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice. Journal of Medical Microbiology. 56: 443-53. PMID 17374882 DOI: 10.1099/Jmm.0.46880-0  0.388
2007 DiGiandomenico A, Rao J, Harcher K, Zaidi TS, Gardner J, Neely AN, Pier GB, Goldberg JB. Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proceedings of the National Academy of Sciences of the United States of America. 104: 4624-9. PMID 17360574 DOI: 10.1073/Pnas.0608657104  0.464
2007 Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infection and Immunity. 75: 1598-608. PMID 17283089 DOI: 10.1128/Iai.01980-06  0.788
2007 Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedón JC, Pier GB, Weiss ST. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatric Pulmonology. 42: 256-62. PMID 17245735 DOI: 10.1002/Ppul.20563  0.355
2007 Gening ML, Tsvetkov YE, Pier GB, Nifantiev NE. Synthesis of beta-(1-->6)-linked glucosamine oligosaccharides corresponding to fragments of the bacterial surface polysaccharide poly-N-acetylglucosamine. Carbohydrate Research. 342: 567-75. PMID 16952342 DOI: 10.1016/J.Carres.2006.08.010  0.316
2007 Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L. Human mAbs to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. Journal of Immunology. 178: 7485-7485. DOI: 10.4049/Jimmunol.178.11.7485  0.407
2006 Knirel YA, Bystrova OV, Kocharova NA, Zähringer U, Pier GB. Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa. Journal of Endotoxin Research. 12: 324-36. PMID 17254386 DOI: 10.1177/09680519060120060201  0.315
2006 Pier GB. Airway epithelial (nasal) cell monolayers used to study Pseudomonas aeruginosa invasion are hyperpolarized and not representative of the human airway epithelium. Infection and Immunity. 74: 7043; author reply 7. PMID 17116966 DOI: 10.1128/Iai.01233-06  0.374
2006 Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infection and Immunity. 74: 4849-55. PMID 16861673 DOI: 10.1128/Iai.00230-06  0.476
2006 Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infection and Immunity. 74: 2742-50. PMID 16622211 DOI: 10.1128/Iai.74.5.2742-2750.2006  0.789
2006 Zaidi TS, Priebe GP, Pier GB. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Infection and Immunity. 74: 975-83. PMID 16428743 DOI: 10.1128/Iai.74.2.975-983.2006  0.471
2006 Bystrova OV, Knirel YA, Lindner B, Kocharova NA, Kondakova AN, Zähringer U, Pier GB. Structures of the core oligosaccharide and O-units in the R- and SR-type lipopolysaccharides of reference strains of Pseudomonas aeruginosa O-serogroups. Fems Immunology and Medical Microbiology. 46: 85-99. PMID 16420601 DOI: 10.1111/J.1574-695X.2005.00004.X  0.306
2005 Cerca N, Martins S, Sillankorva S, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Applied and Environmental Microbiology. 71: 8677-82. PMID 16332862 DOI: 10.1128/Aem.71.12.8677-8682.2005  0.325
2005 Kelly-Quintos C, Kropec A, Briggs S, Ordonez CL, Goldmann DA, Pier GB. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine. The Journal of Infectious Diseases. 192: 2012-9. PMID 16267775 DOI: 10.1086/497604  0.777
2005 Anisimov AP, Dentovskaya SV, Titareva GM, Bakhteeva IV, Shaikhutdinova RZ, Balakhonov SV, Lindner B, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA. Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B. Infection and Immunity. 73: 7324-31. PMID 16239530 DOI: 10.1128/Iai.73.11.7324-7331.2005  0.334
2005 Pier G. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections. Expert Review of Vaccines. 4: 645-656. PMID 16221066 DOI: 10.1586/14760584.4.5.645  0.436
2005 Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Götz F, Goldmann DA, Pier GB. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection Infection and Immunity. 73: 6868-6876. PMID 16177366 DOI: 10.1128/Iai.73.10.6868-6876.2005  0.453
2005 Reiniger N, Ichikawa JK, Pier GB. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infection and Immunity. 73: 6822-30. PMID 16177360 DOI: 10.1128/Iai.73.10.6822-6830.2005  0.79
2005 Maira-Litrán T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infection and Immunity. 73: 6752-62. PMID 16177353 DOI: 10.1128/Iai.73.10.6752-6762.2005  0.463
2005 Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. The Journal of Infectious Diseases. 192: 410-9. PMID 15995954 DOI: 10.1086/431516  0.428
2005 Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. The Journal of Antimicrobial Chemotherapy. 56: 331-6. PMID 15980094 DOI: 10.1093/Jac/Dki217  0.327
2005 Cerca N, Martins S, Pier GB, Oliveira R, Azeredo J. The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm. Research in Microbiology. 156: 650-5. PMID 15950124 DOI: 10.1016/J.Resmic.2005.02.004  0.317
2005 Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrobial Agents and Chemotherapy. 49: 2467-73. PMID 15917548 DOI: 10.1128/Aac.49.6.2467-2473.2005  0.355
2005 Cerca N, Pier GB, Vilanova M, Oliveira R, Azeredo J. Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis Research in Microbiology. 156: 506-514. PMID 15862449 DOI: 10.1016/J.Resmic.2005.01.007  0.381
2005 Lai Z, Kimmel R, Petersen S, Thomas S, Pier G, Bezabeh B, Luo R, Schreiber JR. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Vaccine. 23: 3264-71. PMID 15837231 DOI: 10.1016/J.Vaccine.2005.01.088  0.459
2005 Koh AY, Priebe GP, Pier GB. Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia Infection and Immunity. 73: 2262-2272. PMID 15784570 DOI: 10.1128/Iai.73.4.2262-2272.2005  0.413
2005 Knirel YA, Lindner B, Vinogradov EV, Kocharova NA, Senchenkova N, Shaikhutdinova RZ, Dentovskaya SV, Fursova NK, Bakhteeva IV, Titareva GM, Balakhonov SV, Gremyakova A, Pier GB, Anisimov AP, Zelinsky ND. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry. 44: 1731-1743. PMID 15683257 DOI: 10.1021/Bi048430F  0.302
2004 Zaidi T, Mowrey-McKee M, Pier GB. Hypoxia increases corneal cell expression of CFTR leading to increased Pseudomonas aeruginosa binding, internalization, and initiation of inflammation Investigative Ophthalmology and Visual Science. 45: 4066-4074. PMID 15505057 DOI: 10.1167/Iovs.04-0627  0.406
2004 Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. Journal of Immunology (Baltimore, Md. : 1950). 173: 5671-8. PMID 15494518 DOI: 10.4049/Jimmunol.173.9.5671  0.435
2004 Cerca N, Pier GB, Vilanova M, Oliveira R, Azeredo J. Influence of batch or fed-batch growth on Staphylococcus epidermidis biofilm formation Letters in Applied Microbiology. 39: 420-424. PMID 15482432 DOI: 10.1111/J.1472-765X.2004.01601.X  0.308
2004 Priebe GP, Dean CR, Zaidi T, Meluleni GJ, Coleman FT, Coutinho YS, Noto MJ, Urban TA, Pier GB, Goldberg JB. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infection and Immunity. 72: 4224-32. PMID 15213167 DOI: 10.1128/Iai.72.7.4224-4232.2004  0.436
2004 Anisimov AP, Lindler LE, Pier GB. Intraspecific Diversity of Yersinia pestis Clinical Microbiology Reviews. 17: 434-464. PMID 15084509 DOI: 10.1128/Cmr.17.2.434-464.2004  0.306
2004 Jefferson KK, Pier DB, Goldmann DA, Pier GB. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. Journal of Bacteriology. 186: 2449-56. PMID 15060048 DOI: 10.1128/Jb.186.8.2449-2456.2004  0.328
2004 Maira-Litran T, Kropec A, Goldmann D, Pier GB. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide Vaccine. 22: 872-879. PMID 15040940 DOI: 10.1016/J.Vaccine.2003.11.033  0.421
2004 Walker RI, Blanchard T, Braun JM, Cebra JJ, Cross AS, Fattom A, Giannasca PJ, Holder IA, Huebner J, Matthews R, Pier GB, Romani L, von Specht BU, Trautmann M. Meeting summary: possibilities for active and passive vaccination against opportunistic infections. Vaccine. 22: 801-4. PMID 15040930 DOI: 10.1016/J.Vaccine.2003.11.042  0.346
2004 Krueger WA, Krueger-Rameck S, Koch S, Carey V, Pier GB, Huebner J. Assessment of the role of antibiotics and enterococcal virulence factors in a mouse model of extraintestinal translocation Critical Care Medicine. 32: 467-471. PMID 14758165 DOI: 10.1097/01.Ccm.0000109447.04893.48  0.37
2004 Kowalski MP, Pier GB. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. Journal of Immunology (Baltimore, Md. : 1950). 172: 418-25. PMID 14688350 DOI: 10.4049/Jimmunol.172.1.418  0.701
2003 Pier GB. Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen Carbohydrate Research. 338: 2549-2556. PMID 14670716 DOI: 10.1016/S0008-6215(03)00312-4  0.39
2003 Cabrol S, Olliver A, Pier GB, Andremont A, Ruimy R. Transcription of Quorum-Sensing System Genes in Clinical and Environmental Isolates of Pseudomonas aeruginosa Journal of Bacteriology. 185: 7222-7230. PMID 14645283 DOI: 10.1128/Jb.185.24.7222-7230.2003  0.312
2003 Cannon CL, Kowalski MP, Stopak KS, Pier GB. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. American Journal of Respiratory Cell and Molecular Biology. 29: 188-97. PMID 12878584 DOI: 10.1165/Rcmb.4898  0.689
2003 Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infection and Immunity. 71: 3875-84. PMID 12819072 DOI: 10.1128/Iai.71.7.3875-3884.2003  0.489
2003 Jefferson KK, Cramton SE, Götz F, Pier GB. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Molecular Microbiology. 48: 889-99. PMID 12753184 DOI: 10.1046/J.1365-2958.2003.03482.X  0.35
2003 Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, Grimm KM, Roper K, Ip CC, Cope L, Montgomery D, Chang M, Campie S, Brown M, McNeely TB, ... ... Pier GB, et al. Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydrate Research. 338: 903-22. PMID 12681914 DOI: 10.1016/S0008-6215(03)00045-4  0.376
2003 Priebe GP, Meluleni GJ, Coleman FT, Goldberg JB, Pier GB. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infection and Immunity. 71: 1453-61. PMID 12595463 DOI: 10.1128/Iai.71.3.1453-1461.2003  0.434
2003 Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proceedings of the National Academy of Sciences of the United States of America. 100: 1949-54. PMID 12578988 DOI: 10.1073/Pnas.0437901100  0.433
2003 Krueger W, Escher M, Woll A, Gross M, Muscholl-Silberhorn A, Vollmer I, Krueger-Rameck S, Unertl K, Götz F, Pier G. Critical Care. 7: P041. DOI: 10.1186/Cc1930  0.351
2002 Lyczak JB, Pier GB. Salmonella enterica serovar Typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium Infection and Immunity. 70: 6416-6423. PMID 12379722 DOI: 10.1128/Iai.70.11.6416-6423.2002  0.387
2002 Maira-Litrán T, Kropec A, Abeygunawardana C, Joyce J, Mark G, Goldmann DA, Pier GB. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infection and Immunity. 70: 4433-40. PMID 12117954 DOI: 10.1128/Iai.70.8.4433-4440.2002  0.4
2002 Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerçeker AA, Golan DE, Pier GB. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proceedings of the National Academy of Sciences of the United States of America. 99: 6907-12. PMID 11997458 DOI: 10.1073/Pnas.092160899  0.427
2002 Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clinical Microbiology Reviews. 15: 194-222. PMID 11932230 DOI: 10.1128/Cmr.15.2.194-222.2002  0.401
2002 Priebe GP, Brinig MM, Hatano K, Grout M, Coleman FT, Pier GB, Goldberg JB. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Infection and Immunity. 70: 1507-17. PMID 11854239 DOI: 10.1128/Iai.70.3.1507-1517.2002  0.408
2002 Pier GB. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection Current Opinion in Microbiology. 5: 81-86. PMID 11834374 DOI: 10.1016/S1369-5274(02)00290-4  0.447
2001 Lyczak JB, Zaidi TS, Grout M, Bittner M, Contreras I, Pier GB. Epithelial cell contact‐induced alterations in Salmonella enterica serovar Typhi lipopolysaccharide are critical for bacterial internalization Cellular Microbiology. 3: 763-772. PMID 11696036 DOI: 10.1046/J.1462-5822.2001.00154.X  0.37
2001 Knirel YA, Bystrova OV, Shashkov AS, Lindner B, Kocharova NA, Senchenkova SN, Moll H, Zähringer U, Hatano K, Pier GB. Structural analysis of the lipopolysaccharide core of a rough, cystic fibrosis isolate of Pseudomonas aeruginosa Febs Journal. 268: 4708-4719. PMID 11532007 DOI: 10.1046/J.1432-1327.2001.02396.X  0.327
2001 Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, Pier GB. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. Journal of Immunology (Baltimore, Md. : 1950). 166: 7410-8. PMID 11390493 DOI: 10.4049/Jimmunol.166.12.7410  0.788
2001 Park PW, Pier GB, Hinkes MT, Bernfield M. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence Nature. 411: 98-102. PMID 11333985 DOI: 10.1038/35075100  0.459
2001 Hemachandra S, Kamboj K, Copfer J, Pier G, Green LL, Schreiber JR. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infection and Immunity. 69: 2223-9. PMID 11254577 DOI: 10.1128/Iai.69.4.2223-2229.2001  0.469
2001 Pier GB, Coleman F, Grout M, Franklin M, Ohman DE. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infection and Immunity. 69: 1895-901. PMID 11179370 DOI: 10.1128/Iai.69.3.1895-1901.2001  0.446
2001 Schroeder TH, Zooid T, Pier GB. Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM1 on epithelial cells Infection and Immunity. 69: 719-729. PMID 11159960 DOI: 10.1128/Iai.69.2.719-729.2001  0.47
2001 Lyczak JB, Pier GB. Regulation of the gastrointestinal epithelial cell expression of CFTR protein by Salmonella enterica serovar Typhi, and its importance to infection and development of typhoid fever Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)83516-0  0.369
2000 Goldberg JB, Pier GB. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis Trends in Microbiology. 8: 514-520. PMID 11121762 DOI: 10.1016/S0966-842X(00)01872-2  0.427
2000 Mckenney D, Pouliot K, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB. Vaccine potential of poly-1-6 β-d-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis Journal of Biotechnology. 83: 37-44. PMID 11000458 DOI: 10.1016/S0168-1656(00)00296-0  0.481
2000 Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes and Infection / Institut Pasteur. 2: 1051-60. PMID 10967285 DOI: 10.1016/S1286-4579(00)01259-4  0.374
2000 Pier GB. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections Proceedings of the National Academy of Sciences of the United States of America. 97: 8822-8828. PMID 10922041 DOI: 10.1073/Pnas.97.16.8822  0.472
2000 Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci Infection and Immunity. 68: 4631-4636. PMID 10899866 DOI: 10.1128/Iai.68.8.4631-4636.2000  0.473
2000 Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infection and Immunity. 68: 3998-4004. PMID 10858214 DOI: 10.1128/Iai.68.7.3998-4004.2000  0.451
2000 Pier GB. Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides - Players in the predicament of cystic fibrosis patients Trends in Microbiology. 8: 247-250. PMID 10838574 DOI: 10.1016/S0966-842X(00)01743-1  0.424
2000 Park PW, Pier GB, Preston MJ, Goldberger O, Fitzgerald ML, Bernfield M. Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. The Journal of Biological Chemistry. 275: 3057-64. PMID 10652286 DOI: 10.1074/Jbc.275.5.3057  0.397
2000 Gerçeker AA, Zaidi T, Marks P, Golan DE, Pier GB. Impact of heterogeneity within cultured cells on bacterial invasion: analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductance regulator receptor. Infection and Immunity. 68: 861-70. PMID 10639456 DOI: 10.1128/Iai.68.2.861-870.2000  0.366
1999 Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infection and Immunity. 67: 4744-50. PMID 10456926 DOI: 10.1128/Iai.67.9.4744-4750.1999  0.653
1999 Wang Y, Huebner J, Tzianabos AO, Martirosian G, Kasper DL, Pier GB. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydrate Research. 316: 155-60. PMID 10420594 DOI: 10.1016/S0008-6215(99)00046-4  0.318
1999 Dean CR, Franklund CV, Retief JD, Coyne MJ, Hatano K, Evans DJ, Pier GB, Goldberg JB. Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. Journal of Bacteriology. 181: 4275-84. PMID 10400585 DOI: 10.1128/Jb.181.14.4275-4284.1999  0.315
1999 McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284: 1523-1527. PMID 10348739 DOI: 10.1126/Science.284.5419.1523  0.465
1999 Zaidi TS, Lyczak J, Preston M, Pier GB. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis Infection and Immunity. 67: 1481-1492. PMID 10024598 DOI: 10.1128/Iai.67.3.1481-1492.1999  0.425
1999 Huebner J, Wang Y, Krueger WA, Madoff LC, Martirosian G, Boisot S, Goldmann DA, Kasper DL, Tzianabos AO, Pier GB. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infection and Immunity. 67: 1213-9. PMID 10024563 DOI: 10.1128/Iai.67.3.1213-1219.1999  0.425
1999 Pier GB. Evolution of the ΔF508 CFTR mutation: Response Trends in Microbiology. 7: 56-58. DOI: 10.1016/S0966-842X(98)01441-3  0.456
1998 McKenney D, Hübner J, Muller E, Wang Y, Goldmann DA, Pier GB. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infection and Immunity. 66: 4711-4720. PMID 9746568 DOI: 10.1128/Iai.66.10.4711-4720.1998  0.43
1998 Preston MJ, Gerçeker AA, Reff ME, Pier GB. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide Infection and Immunity. 66: 4137-4142. PMID 9712759 DOI: 10.1128/Iai.66.9.4137-4142.1998  0.446
1998 Hatano K, Pier GB. Complex serology and immune response of mice to variant high-molecular- weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains Infection and Immunity. 66: 3719-3726. PMID 9673254 DOI: 10.1128/Iai.66.8.3719-3726.1998  0.41
1998 Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ, Colledge WH. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature. 393: 79-82. PMID 9590693 DOI: 10.1038/30006  0.39
1997 Pier GB. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients Behring Institute Mitteilungen. 350-360. PMID 9382760  0.398
1997 Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung Proceedings of the National Academy of Sciences of the United States of America. 94: 12088-12093. PMID 9342367 DOI: 10.1073/Pnas.94.22.12088  0.418
1997 Preston MJ, Seed PC, Toder DS, Iglewski BH, Ohman DE, Gustin JK, Goldberg JB, Pier GB. Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. Infection and Immunity. 65: 3086-90. PMID 9234758 DOI: 10.1128/Iai.65.8.3086-3090.1997  0.397
1997 Preston MJ, Alev Gerçeker A, Koles NL, Pollack M, Pier GB. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection Investigative Ophthalmology and Visual Science. 38: 1418-1425. PMID 9191605  0.372
1997 Zaidi TS, Preston MJ, Pier GB. Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosa corneal infection Infection and Immunity. 65: 1370-1376. PMID 9119476 DOI: 10.1128/Iai.65.4.1370-1376.1997  0.433
1997 Fleiszig SM, Evans DJ, Mowrey-McKee MF, Payor R, Zaidi TS, Vallas V, Muller E, Pier GB. Factors affecting Staphylococcus epidermidis adhesion to contact lenses. Optometry and Vision Science : Official Publication of the American Academy of Optometry. 73: 590-4. PMID 8887402 DOI: 10.1097/00006324-199609000-00005  0.335
1996 Goldberg JB, Pier GB. Pseudomonas aeruginosa lipopolysaccharides and pathogenesis Trends in Microbiology. 4: 490-494. PMID 9004407 DOI: 10.1016/S0966-842X(97)82911-3  0.354
1996 Pier GB, Grout M, Zaidi TS, Goldberg JB. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis American Journal of Respiratory and Critical Care Medicine. 154. PMID 8876538 DOI: 10.1164/Ajrccm/154.4_Pt_2.S175  0.456
1996 Pier GB, Tosi MF, Konstan MW, Belger M. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients [6] Journal of Infectious Diseases. 173: 513-515. PMID 8568328 DOI: 10.1093/Infdis/173.2.513  0.406
1996 Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, Goldberg JB. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science (New York, N.Y.). 271: 64-7. PMID 8539601 DOI: 10.1126/Science.271.5245.64  0.446
1996 Fleiszig SM, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infection and Immunity. 64: 2288-2294. DOI: 10.1128/Iai.64.6.2288-2294.1996  0.396
1996 Zaidi TS, Preston MJ, Pier GB. Effect on experimental Pseudomonas aeruginosa corneal infection by inhibiting epithelial cell adherence and ingestion using the complete-core oligosaccharide portion of lipopolysaccharide Investigative Ophthalmology and Visual Science. 37.  0.301
1995 Meluleni GJ, Grout M, Evans DJ, Pier GB. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients Journal of Immunology. 155: 2029-2038. PMID 7636254  0.378
1995 Pollack M, Koles NL, Preston MJ, Brown BJ, Pier GB. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide Infection and Immunity. 63: 4481-4488. PMID 7591089 DOI: 10.1128/Iai.63.11.4481-4488.1995  0.404
1995 Shiro H, Meluleni G, Groll A, Muller E, Tosteson TD, Goldmann DA, Pier GB. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation. 92: 2715-2722. PMID 7586377 DOI: 10.1161/01.Cir.92.9.2715  0.36
1995 Fleiszig SMJ, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro Infection and Immunity. 63: 4072-4077. PMID 7558321 DOI: 10.1128/Iai.63.10.4072-4077.1995  0.404
1995 Pier GB, Meluleni G, Goldberg JB. Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies Infection and Immunity. 63: 2818-2825. PMID 7542632 DOI: 10.1128/Iai.63.8.2818-2825.1995  0.463
1995 Hatano K, Goldberg JB, Pier GB. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate) Infection and Immunity. 63: 21-26. PMID 7528730 DOI: 10.1128/Iai.63.1.21-26.1995  0.463
1995 Preston MJ, Fleiszig SM, Zaidi TS, Goldberg JB, Shortridge VD, Vasil ML, Pier GB. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infection and Immunity. 63: 3497-3501. DOI: 10.1128/Iai.63.9.3497-3501.1995  0.4
1994 Shiro H, Muller E, Gutierrez N, Boisot S, Grout M, Tosteson TD, Goldmann D, Pier GB. Transposon Mutants of Staphylococcus epidermidis Deficient in Elaboration of Capsular Polysaccharide/Adhesin and Slime Are Avirulent in a Rabbit Model of Endocarditis The Journal of Infectious Diseases. 169: 1042-1049. PMID 8169389 DOI: 10.1093/Infdis/169.5.1042  0.384
1994 Fleiszig SMJ, Zaidi TS, Ramphal R, Pier GB. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus Infection and Immunity. 62: 1799-1804. PMID 8168942 DOI: 10.1128/Iai.62.5.1799-1804.1994  0.372
1994 Pier GB, Koles NL, Meluleni G, Hatano K, Pollack M. Specificity and function of murine monoclonal antibodies and immunization- induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06 Infection and Immunity. 62: 1137-1143. PMID 8132318 DOI: 10.1128/Iai.62.4.1137-1143.1994  0.428
1994 Pier GB, DesJardin D, Grout M, Garner C, Bennett SE, Pekoe G, Fuller SA, Thornton MO, Harkonen WS, Miller HC. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infection and Immunity. 62: 3972-9. PMID 8063415 DOI: 10.1128/Iai.62.9.3972-3979.1994  0.457
1994 Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infection and Immunity. 62: 3485-93. PMID 8039920 DOI: 10.1128/Iai.62.8.3485-3493.1994  0.437
1994 Fleiszig SMJ, Zaidi TS, Pier GB. Mucus and pseudomonas aeruginosa adherence to the cornea Advances in Experimental Medicine and Biology. 350: 359-362. PMID 8030502 DOI: 10.1007/978-1-4615-2417-5_62  0.356
1994 Evans DJ, Pier GB, Coyne MJ, Goldberg JB. The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients Molecular Microbiology. 13: 427-434. PMID 7527892 DOI: 10.1111/J.1365-2958.1994.Tb00437.X  0.393
1994 Hatano K, Boisot S, DesJardins D, Wright DC, Brisker J, Pier GB. Immunogenic and antigenic properties of a heptavalent high-molecular- weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa Infection and Immunity. 62: 3608-3616. PMID 7520416 DOI: 10.1128/Iai.62.9.3608-3616.1994  0.428
1993 Goldmann DA, Pier GB. Pathogenesis of infections related to intravascular catheterization Clinical Microbiology Reviews. 6: 176-192+C+. PMID 8472248 DOI: 10.1128/Cmr.6.2.176  0.34
1993 Pier GB, Takeda S, Grout M, Markham RB. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa Journal of Clinical Investigation. 91: 1079-1087. PMID 8450038 DOI: 10.1172/Jci116265  0.479
1993 Goldberg JB, Hatano K, Pier GB. Synthesis of lipopolysaccharide O side chains by Pseudomonas aeruginosa PAO1 requires the enzyme phosphomannomutase Journal of Bacteriology. 175: 1605-1611. PMID 8449870 DOI: 10.1128/Jb.175.6.1605-1611.1993  0.323
1993 Mai GT, Seow WK, Pier GB, McCormack JG, Thong YH. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): Reversal by physicochemical, alginase, and specific monoclonal antibody treatments Infection and Immunity. 61: 559-564. PMID 8423085 DOI: 10.1128/Iai.61.2.559-564.1993  0.438
1993 Mai GT, McCormack JG, Seow WK, Pier GB, Jackson LA, Thong YH. Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics Infection and Immunity. 61: 4338-4343. PMID 8406822 DOI: 10.1128/Iai.61.10.4338-4343.1993  0.442
1993 Muller E, Hubner J, Gutierrez N, Takeda S, Goldmann DA, Pier GB. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime Infection and Immunity. 61: 551-558. PMID 8380794 DOI: 10.1128/Iai.61.2.551-558.1993  0.328
1993 Pittet JF, Matthay MA, Pier G, Grady M, Wiener-Kronish JP. Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody. Journal of Clinical Investigation. 92: 1221-1228. PMID 8376581 DOI: 10.1172/Jci116693  0.43
1993 Muller E, Takeda S, Shiro H, Goldmann D, Pier GB. Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci Journal of Infectious Diseases. 168: 1211-1218. PMID 8228355 DOI: 10.1093/Infdis/168.5.1211  0.318
1993 Hatano K, Goldberg JB, Pier GB. Pseudomonas aeruginosa lipopolysaccharide: Evidence that the O side chains and common antigens are on the same molecule Journal of Bacteriology. 175: 5117-5128. PMID 7688717 DOI: 10.1128/Jb.175.16.5117-5128.1993  0.365
1992 Pier GB, Meluleni G, Neuger E. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa Infection and Immunity. 60: 4768-4776. PMID 1398987 DOI: 10.1128/Iai.60.11.4768-4776.1992  0.429
1992 Goldberg JB, Hatano K, Meluleni GS, Pier GB. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli Proceedings of the National Academy of Sciences of the United States of America. 89: 10716-10720. PMID 1279692 DOI: 10.1073/Pnas.89.22.10716  0.404
1991 Takeda S, Pier GB, Kojima Y, Tojo M, Muller E, Tosteson T, Goldmann DA. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 84: 2539-2546. PMID 1959203 DOI: 10.1161/01.Cir.84.6.2539  0.377
1991 Markham RB, Pier GB, Schreiber JR. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa Journal of Immunology. 146: 316-320. PMID 1898604  0.326
1991 Schreiber JR, Nixon KL, Tosi MF, Pier GB, Patawaran MB. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. Journal of Immunology (Baltimore, Md. : 1950). 146: 188-93. PMID 1898598  0.32
1991 Pier GB, Grout M, Desjardins D. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins Journal of Immunology. 147: 1869-1876. PMID 1832427  0.323
1991 Schreiber JR, Pier GB, Grout M, Nixon K, Patawaran M. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody. The Journal of Infectious Diseases. 164: 507-14. PMID 1831226 DOI: 10.1093/Infdis/164.3.507  0.45
1991 Pollack M, Tao M, Akiyama M, Pier GB, Koles NL. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides Antibiotics and Chemotherapy. 44: 163-171. PMID 1801635 DOI: 10.1159/000420311  0.407
1990 Kojima Y, Tojo M, Goldmann DA, Tosteson TD, Pier GB. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci Journal of Infectious Diseases. 162: 435-441. PMID 2373873 DOI: 10.1093/Infdis/162.2.435  0.388
1990 Jones MM, Seilheimer DK, Pier GB, Rossen RD. Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients. Clinical and Experimental Immunology. 80: 344-9. PMID 2142640 DOI: 10.1111/J.1365-2249.1990.Tb03290.X  0.348
1990 Garner CV, DesJardins D, Pier GB. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide Infection and Immunity. 58: 1835-1842. PMID 2140341 DOI: 10.1128/Iai.58.6.1835-1842.1990  0.414
1990 Pier GB, Small GJ, Warren HB. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections Science. 249: 537-540. PMID 2116663 DOI: 10.1126/Science.2116663  0.485
1989 Pier GB. Immunologic properties of Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) Antibiotics and Chemotherapy. 42: 80-87. PMID 2512850 DOI: 10.1159/000417608  0.327
1989 Pier GB, Pollack M. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide Infection and Immunity. 57: 426-431. PMID 2492260 DOI: 10.1128/Iai.57.2.426-431.1989  0.439
1989 Pier GB, Thomas D, Small G, Siadak A, Zweerink H. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide Infection and Immunity. 57: 174-179. PMID 2491835 DOI: 10.1128/Iai.57.1.174-179.1989  0.434
1988 Lee JC, Perez NE, Hopkins CA, Pier GB. Purified capsular polysaccharide-induced immunity to staphylococcus aureus infection Journal of Infectious Diseases. 157: 723-730. PMID 3346565 DOI: 10.1093/Infdis/157.4.723  0.459
1988 Tojo M, Yamashita N, Goldmann DA, Pier GB. Isolation and characterization of a capsular polysaccharide adhesin from staphylococcus epidermidis Journal of Infectious Diseases. 157: 713-722. PMID 3279138 DOI: 10.1093/Infdis/157.4.713  0.37
1988 Pier GB. Polysaccharide antigens of Pseudomonas aeruginosa Reviews of Infectious Diseases. 10. PMID 3142017 DOI: 10.1093/Cid/10.Supplement_2.S337  0.502
1988 Vishwanath S, Ramphal R, Guay CM, DesJardins D, Pier GB. Respiratory-mucin inhibition of the opsonophagocytic killing of Pseudomonas aeruginosa Infection and Immunity. 56: 2218-2222. PMID 3137161 DOI: 10.1128/Iai.56.9.2218-2222.1988  0.467
1988 Kocharova NA, Knirel YA, Shashkov AS, Kochetkov NK, Pier GB. Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4 Journal of Biological Chemistry. 263: 11291-11295. PMID 3136157  0.338
1988 Zweerink HJ, Gammon MC, Hutchison CF, Jackson JJ, Pier GB, Puckett JM, Sewell TJ, Sigal NH. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa. Infection and Immunity. 56: 1209-14. PMID 3128480 DOI: 10.1128/Iai.56.5.1209-1214.1988  0.431
1988 Lukac M, Pier GB, Collier RJ. Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue. Infection and Immunity. 56: 3095-8. PMID 2460407 DOI: 10.1128/Iai.56.12.3095-3098.1988  0.413
1987 Lee JC, Michon F, Perez NE, Hopkins CA, Pier GB. Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus Infection and Immunity. 55: 2191-2197. PMID 3623697 DOI: 10.1128/Iai.55.9.2191-2197.1987  0.385
1987 Speert DP, Dimmick JE, Pier GB, Saunders JM, Hancock REW, Kelly N. An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis Pediatric Research. 22: 743-747. PMID 3431961 DOI: 10.1203/00006450-198712000-00026  0.449
1987 Pennington JE, Pier GB. Pseudomonas aeruginosa immunoglobulin in experimental pneumonia Infection. 15: 56-59. PMID 3106230 DOI: 10.1007/Bf01646124  0.362
1987 Pier GB, Saunders JM, Ames P, Edwards MS, Auerbach H, Goldfarb J, Speert DP, Hurwitch S. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis New England Journal of Medicine. 317: 793-798. PMID 2957591 DOI: 10.1056/Nejm198709243171303  0.394
1987 Ramphal R, Guay C, Pier GB. Pseudomonas aeruginosa adhesins for tracheobronchial mucin Infection and Immunity. 55: 600-603. PMID 2880808 DOI: 10.1128/Iai.55.3.600-603.1987  0.401
1987 Lee JC, Betley MJ, Hopkins CA, Perez NE, Pier GB. Virulence studies, in mice, of transposon-induced mutants of staphylococcus aureus differing in capsule size Journal of Infectious Diseases. 156: 741-750. PMID 2821124 DOI: 10.1093/Infdis/156.5.741  0.357
1986 Parsonnet J, Gillis ZA, Pier GB. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome Journal of Infectious Diseases. 154: 55-63. PMID 3486924 DOI: 10.1093/Infdis/154.1.55  0.345
1986 Pennington JE, Small GJ, Lostrom ME, Pier GB. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia Infection and Immunity. 54: 239-244. PMID 3093385 DOI: 10.1128/Iai.54.1.239-244.1986  0.465
1986 Pier GB, Bennett SE. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide Journal of Clinical Investigation. 77: 491-495. PMID 3080477 DOI: 10.1172/Jci112328  0.434
1986 Pennington JE, Pier GB, Sadoff JC, Small GJ. Active and passive immunization strategies for pseudomonas aeruginosa pneumonia Reviews of Infectious Diseases. 8: 426-433. PMID 2944209 DOI: 10.1093/Clinids/8.Supplement_4.S426  0.454
1986 Pier GB, Desjardins D, Aguilar T, Barnard M, Speert DP. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients Journal of Clinical Microbiology. 24: 189-196. PMID 2943759 DOI: 10.1128/Jcm.24.2.189-196.1986  0.433
1986 Stoll BJ, Pollack M, Young LS, Koles N, Gascon R, Pier GB. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide Infection and Immunity. 53: 656-662. PMID 2427453 DOI: 10.1128/Iai.53.3.656-662.1986  0.419
1986 Powderly WG, Pier GB, Markham RB. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice Journal of Clinical Investigation. 78: 375-380. PMID 2426306 DOI: 10.1172/Jci112587  0.396
1986 Pennington JE, Pier GB, Small GJ. Efficacy of intravenous immune globulin for treatment of experimental Pseudomonas aeruginosa pneumonia Journal of Critical Care. 1: 4-10. DOI: 10.1016/S0883-9441(86)80111-3  0.438
1985 Pier GB. Terminology relating to extracellular polysaccharides produced by pseudomonas aeruginosa Journal of Infectious Diseases. 152: 652. PMID 3928773 DOI: 10.1093/Infdis/152.3.652  0.336
1985 Parsonnet J, Mills JT, Gillis ZA, Pier GB. Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1 Journal of Clinical Microbiology. 22: 26-31. PMID 3926815 DOI: 10.1128/Jcm.22.1.26-31.1985  0.331
1985 Pier GB. Pseudomonas aeruginosa surface polysaccharide vaccines. New therapeutic approaches from basic research Antibiotics and Chemotherapy. 36: 157-167. PMID 3923913  0.429
1985 Pier GB. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: Current status of the host-bacterium interaction Journal of Infectious Diseases. 151: 575-580. PMID 3919113 DOI: 10.1093/Infdis/151.4.575  0.363
1985 Parsonnet J, Hickman RK, Eardley DD, Pier GB. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. The Journal of Infectious Diseases. 151: 514-22. PMID 3871826 DOI: 10.1093/Infdis/151.3.514  0.334
1985 Ames P, DesJardins D, Pier GB. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide Infection and Immunity. 49: 281-285. PMID 3160660 DOI: 10.1128/Iai.49.2.281-285.1985  0.445
1985 Ramphal R, Pier GB. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells Infection and Immunity. 47: 1-4. PMID 3155514 DOI: 10.1128/Iai.47.1.1-4.1985  0.396
1984 Pier GB, Ames P. Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement Journal of Infectious Diseases. 150: 223-228. PMID 6432921 DOI: 10.1093/Infdis/150.2.223  0.444
1984 Pier GB, Pollack M, Cohen M. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 pseudomonas aeruginosa Infection and Immunity. 45: 309-313. PMID 6430805 DOI: 10.1128/Iai.45.2.309-313.1984  0.418
1984 Pollack M, Pier GB, Prescott RK. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice Infection and Immunity. 43: 759-760. PMID 6420347 DOI: 10.1128/Iai.43.2.759-760.1984  0.413
1984 Pier GB, Elcock ME. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa Journal of Immunology. 133: 734-739. PMID 6234359  0.401
1983 Markham RB, Pier GB. Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa Reviews of Infectious Diseases. 5. PMID 6419317 DOI: 10.1093/Clinids/5.Supplement_5.S957  0.466
1983 Pennington JE, Pier GB. Efficacy of cell wall Pseudomonas aeruginosa vaccines for protection against experimental pneumonia Reviews of Infectious Diseases. 5. PMID 6419311 DOI: 10.1093/Clinids/5.Supplement_5.S852  0.381
1983 Pier GB, Cohen M, Jennings H. Further purification and characterization of high-molecular-weight polysaccharide from Pseudomonas aeruginosa Infection and Immunity. 42: 936-941. PMID 6417026 DOI: 10.1128/Iai.42.3.936-941.1983  0.345
1983 Hancock REW, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains Infection and Immunity. 42: 170-177. PMID 6413410 DOI: 10.1128/Iai.42.1.170-177.1983  0.391
1983 Pier GB, Thomas DM. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa Journal of Infectious Diseases. 148: 206-213. PMID 6411830 DOI: 10.1093/Infdis/148.2.206  0.434
1983 Markham RB, Pier GB. Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1 Infection and Immunity. 41: 232-236. PMID 6407998 DOI: 10.1128/Iai.41.1.232-236.1983  0.434
1983 Griffiss JM, Brandt BL, Altieri PL, Pier GB, Berman SL. Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults Infection and Immunity. 39: 247-252. PMID 6401693 DOI: 10.1128/Iai.39.1.247-252.1983  0.338
1983 Pier GB, Matthews WJ, Eardley DD. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. The Journal of Infectious Diseases. 147: 494-503. PMID 6220094 DOI: 10.1093/Infdis/147.3.494  0.454
1983 Pier GB. Immunochemistry of Pseudomonas aeruginosa lipopolysaccharides and high-molecular-weight polysaccharides Reviews of Infectious Diseases. 5. PMID 6197738 DOI: 10.1093/Clinids/5.Supplement_5.S950  0.335
1982 Pier GB. Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype I Pseudomonas aeruginosa Journal of Clinical Investigation. 69: 303-308. PMID 6799548 DOI: 10.1172/Jci110453  0.327
1982 Pier GB, Thomas DM. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of pseudomonas aeruginosa Journal of Infectious Diseases. 145: 217-223. PMID 6798136 DOI: 10.1093/Infdis/145.2.217  0.359
1982 Pier GB. Cross-protection by Pseudomonas aeruginosa polysaccharides Infection and Immunity. 38: 1117-1122. PMID 6185423 DOI: 10.1128/Iai.38.3.1117-1122.1982  0.393
1982 Pier GB, Markham RB. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine Journal of Immunology. 128: 2121-2125. PMID 6174622  0.312
1981 Griffiss JM, Brandt BL, Altieri PL, Pier GB, Berman SL. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults Infection and Immunity. 34: 725-732. PMID 6800954 DOI: 10.1128/Iai.34.3.725-732.1981  0.319
1981 Macone AB, Pier GB, Pennington JE, Matthews WJ, Goldmann DA. Mucoid Escherichia coli in cystic fibrosis. The New England Journal of Medicine. 304: 1445-9. PMID 6785645 DOI: 10.1056/Nejm198106113042401  0.399
1981 Pier GB, Sidberry HF, Sadoff JC. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2 Infection and Immunity. 34: 461-468. PMID 6171520 DOI: 10.1128/Iai.34.2.461-468.1981  0.416
1978 Pier GB, Sidberry HF, Sadoff JC. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa Infection and Immunity. 22: 919-925. PMID 103841 DOI: 10.1128/Iai.22.3.919-925.1978  0.415
Show low-probability matches.